Navigation Links
Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding
Date:1/29/2008

OXFORD, England, January 29 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, announced today that it has successfully raised GBP11 million ($21.8 million) in an oversubscribed second round funding. The investment syndicate includes new investors Goldman Sachs and Invesco Perpetual, as well as existing investors, including Imperial Innovations and Lansdowne Partners.

"Completing this financing is a testament to the potential of Circassia's business, management and technology," said Steve Harris, Circassia's CEO. "We have made good progress advancing our anti-allergy products during the last year, and successfully completing this funding, particularly in the current challenging market conditions, is a strong vote of confidence from a syndicate of world-class investors."

Circassia, whose immune control technologies target allergies and organ rejection, completed an initial investment round of GBP6 million ($11.8 million) in January 2007. During the last year the company has finalised preparations to complete the phase II clinical testing programme for its lead product against cat dander allergy, and finalised the acquisition of its ToleroTrans organ anti-rejection technology. Following this second investment round, Circassia has increased its current cash balance to GBP15 million ($29.8 million), and plans to utilise the funds both to progress its clinical development programmes and to acquire additional technologies that fit its specialty business model.

Circassia's products have the potential to address significant market opportunities. Currently, over 150 million people suffer from allergic rhinitis in the US and Europe, and existing treatments either provide symptomatic relief only or require lengthy specialist physician supervision over a period of many months due to potential serious, even life-threatening, adverse reactions. In contrast, Circassia's technology uses sm
'/>"/>

SOURCE Circassia Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Primera Biosystems Raises $21 Million in Series B Private Round
2. Cellectar, Inc. Raises $13 Million in Private Offering
3. Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
4. Anesiva Raises $45 Million in Common Stock Offering
5. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance
6. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
9. VisEn Medical Raises $7 Million in Series B Financing
10. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
11. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... -- Immune Pharmaceuticals Inc., or "Immune" (NASDAQ: IMNP ... Rene-Pierre Azria as a Director and the ... on strategic and financial transactions. Mr. Azria will also ... Committee and the Corporate Governance and Nomination Committee. ... a long-time interest in Life Sciences and in particular ...
(Date:4/21/2015)... San Bruno, CA (PRWEB) April 21, 2015 ... Expert CRO, will sponsor and exhibit at the ACRP ... in Salt Lake City, Utah. The Association of Clinical ... largest annual clinical research conference solely focused on the ... through membership, training and development, and widely recognized industry ...
(Date:4/21/2015)... April 21, 2015 Whether it’s used for ... or bolted to a Kessler CineDrive in a ... the beach, the TS3-H is designed to help any shooter ... brand-new state-of-the-art 5MP sensor, the TS5-H offers the same convenient ... imaging characteristics. , According to Tom Boldt for Fastec, ...
(Date:4/20/2015)... Orthobiologics are substances that are ... orthobiologics market is a rewarding market, which represents a ... orthobiologics market report defines and segments the concerned market ... market was valued at $5,712.4 million in 2014, and ... a CAGR of 6.7% from 2014 to 2019. ...
Breaking Biology Technology:Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 2Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 4PRC Clinical Sponsors The ACRP 2015 Global Conference And Meets Biotech Companies in the Salt Lake City Area. 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 3Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3
... LAVAL, QC, Oct. 21 /PRNewswire-FirstCall/ - Acasti Pharma ... Inc.,("Neptune") (NASDAQ.NEPT - TSX.V.NTB) today announced that it ... issued by Neptune on,August 11, 2008 in payment ... offered to acquire the notes in exchange for ...
... Terumo Heart, Inc. announced,today that five patients have ... an important early milestone in the U.S.,Pivotal Trial. ... the five implants,at the University of Michigan Cardiovascular ... performed off-pump., "We congratulate Dr. Pagani on ...
... to drive innovation and product ... development for NewCardio, ... Board: NWCI) a cardiac diagnostic and services company, today,announced Dorin ... Officer and Vice-President of Research and Development, effective,October 20. Dr. ...
Cached Biology Technology:Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes 2Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes 3Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial 2Dorin Panescu Named NewCardio's Chief Technical Officer 2Dorin Panescu Named NewCardio's Chief Technical Officer 3Dorin Panescu Named NewCardio's Chief Technical Officer 4
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... and Voice Biometrics - Global Strategic Business Report" report to ... Face and Voice Biometrics in US$ Thousands by the following Segments: ... for the US, Canada , Japan ... , Middle East & Africa ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... 2010 New evidence that genetics play a significant role ... can do everything right and still give birth too soon. ... for Maternal-Fetal Medicine (SMFM) meeting -- The Pregnancy Meeting -- ... fetus can make them susceptible to an inflammatory response that ...
... Himalayan mountains are thinning is not disputed. However, few ... causes. Lawrence Berkeley National Laboratory scientist Surabi Menon set ... blamed culpritgreenhouse gases, such as carbon dioxidefrom other particles ... Menon and her collaborators found that airborne black carbon ...
... could predict which patients with the lung-scarring disease known as ... an indicator that could one day influence their treatment, according ... Their findings, published online last week in PLoS One ... tissue, suggesting that IPF is in fact an immunologic disease. ...
Cached Biology News:New research shows genes of pregnant women and their fetuses can increase the risk of preterm labor 2Black carbon a significant factor in melting of Himalayan glaciers 2Black carbon a significant factor in melting of Himalayan glaciers 3Test could predict which idiopathic pulmonary fibrosis patients will become severely ill 2
A collection of 42 spots with normal tissues from different organs of C57 mice, rat and human....
... which is based on a new flow-through technology, ... in situ hybridization of tissues on microscope slide ... study of gene expression, in situ hybridization (ISH) ... can be used to validate and confirm results ...
... voice-coil scanning and positioning system is ... have to be positioned or scanned ... It provides superior responsiveness compared to ... mechanics (X or XY stage) are ...
... Analyst Software has been optimized for the ... allow the software to quickly and accurately ... well of an ELISA plate or each ... Software has been customized to incorporate standard ...
Biology Products: